Andrew Webb’s role at ProtonDx leverages over 30 years of commercial experience in the diagnostics and life Sciences industry. He is currently CEO at Extruded Pharmaceuticals prior to which he was Chief Commercial Officer at Novel Technologies Holdings. Before then he was Chief Executive Officer and founder of EKF Molecular Diagnostics and a NED at Arcis Biotechnology. Previously Senior Director at Qiagen following the acquisition of DxS where he was Commercial Director. Andrew Webb has also worked at Amersham/GE Healthcare following 5 years in pre‑clinical research at GlaxoSmithKline.